drugset / Trial / NCT00400335

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

NCT00400335

Phase 1 Completed 60 enrolled GlaxoSmithKline
RandomizedParallel-groupOpen-labelTreatment

Summary

The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Timeline

Start
2006-10
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule
Subject Testosterone Small molecule

Indications